Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which includes trauma, spine, hand and upper extremity, total joints and even pediatric orthopedics.
This report contains market size and forecasts of Orthopedic Oncology Treatment in Global, including the following market information:
Global Orthopedic Oncology Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Orthopedic Oncology Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Soft Tissue Excisions/Resections Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orthopedic Oncology Treatment include Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, DePuy Synthes (Johnson & Johnson), Medtronic, Accentus Medical, Roche Holding AG, Amgen, Inc. and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orthopedic Oncology Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orthopedic Oncology Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Orthopedic Oncology Treatment Market Segment Percentages, by Type, 2021 (%)
Soft Tissue Excisions/Resections
Limb Salvage Surgery
Amputation
Adjuvant Chemotherapy
Reconstructive Surgery
Global Orthopedic Oncology Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Orthopedic Oncology Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Orthopedic Oncology Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Orthopedic Oncology Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orthopedic Oncology Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Orthopedic Oncology Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
DePuy Synthes (Johnson & Johnson)
Medtronic
Accentus Medical
Roche Holding AG
Amgen, Inc.
Novartis AG
GlaxoSmithKline
Sanofi
Pfizer Inc.